<DOC>
	<DOCNO>NCT02180945</DOCNO>
	<brief_summary>The objective study evaluate safety ( 1 month ) performance ( 3-6 month ) post last embolization Onyx Onyx associate embolization product ( cyanoacrylate glue , coil , balloon , otherâ€¦ )</brief_summary>
	<brief_title>ONYX Evaluation Endovascular Treatment Intracranial Dural Arteriovenous Fistulae</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<mesh_term>Central Nervous System Vascular Malformations</mesh_term>
	<criteria>The patient intracranial dAVF could treat ONYX embolization , whether associate embolization product . The patient least 18 year age . The patient need treat dAVF another treatment option ( example surgery ) embolization within period le 6 month ( count first treatment ) The patient participate another clinical study treatment period his/her dAVF , evaluate another medical device , procedure medication . The patient refuse give consent collection process data require centralized monitoring . A condition could jeopardize followup patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>dAVF</keyword>
	<keyword>Arteriovenous fistula</keyword>
	<keyword>ONYX</keyword>
</DOC>